北京美科美生物公司代理Oncovir

Hiltonol’s® 


Oncovir，Inc是一家制药公司，致力于开发基于核酸的临床疗法，用于治疗癌症、传染性疾病、免疫疾病和退行性疾病。

我们提倡Hiltonol®（poly ICLC）作为一种实验性病毒模拟物和广泛的先天性和适应性免疫激活剂。Hiltonol®最初是作为干扰素诱导剂开发的，但在人体内具有更广泛的生物学效应，包括特异性抗病毒、免疫激活、疫苗佐剂和抗肿瘤作用
Oncovir, Inc is a pharmaceutical corporation dedicated to the development of nucleic-acid-based clinical therapies for cancer, infectious, immune, and degenerative disorders.
​
We promote Hiltonol® (poly-ICLC) as an experimental viral mimic and broad activator of innate and adaptive immunity. While initially developed as an interferon inducer, Hiltonol® has much broader biological effects in humans, including specific antiviral, immune activating, vaccine adjuvant, and antitumor actions